Sign inGet started

Morrison Scott W

Insider CIK 1662426 · CRVS Director · BOLD Director · GBT Director · IDYA Director · ZLAB Director · TARS Director · VERA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
TARS Tarsus Pharmaceuticals, In A Award deriv2026-06-252026-06-293,837— $03,837SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2026-06-252026-06-292,417— $02,417SEC↗
ZLAB Zai Lab Ltd A Award2026-06-172026-06-2222,371— $056,904SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2026-06-162026-06-1820,000— $020,000SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2026-06-122026-06-162,954— $00SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2026-06-122026-06-162,954— $07,638SEC↗
VERA Vera Therapeutics, Inc. A Award deriv2026-05-212026-05-2617,084— $017,084SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2025-09-152025-09-161,334— $00SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2025-09-152025-09-161,334— $04,684SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2025-06-242025-06-2620,000— $020,000SEC↗
ZLAB Zai Lab Ltd A Award2025-06-182025-06-2310,831— $034,533SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2025-06-132025-06-163,350— $00SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2025-06-132025-06-163,350— $03,350SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2025-06-122025-06-164,540— $04,540SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2025-06-122025-06-162,954— $02,954SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2025-06-122025-06-1615,000— $015,000SEC↗
VERA Vera Therapeutics, Inc. A Award deriv2025-05-142025-05-1614,000— $014,000SEC↗
ZLAB Zai Lab Ltd S Sale2025-05-092025-05-1323,799$30.05 $715.2K23,702SEC↗
TARS Tarsus Pharmaceuticals, In G Gift2024-09-302024-10-026,016— $00SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2024-09-152024-09-171,333— $01,334SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2024-09-152024-09-171,333— $06,016SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2024-06-242024-06-253,350— $00SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2024-06-242024-06-253,350— $04,683SEC↗
ZLAB Zai Lab Ltd A Award2024-06-182024-06-2021,253— $047,501SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2024-06-132024-06-143,350— $03,350SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2024-06-132024-06-145,000— $05,000SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2024-06-132024-06-1715,000— $015,000SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2024-05-312024-05-3116,200— $016,200SEC↗
VERA Vera Therapeutics, Inc. A Award deriv2024-05-152024-05-1714,000— $014,000SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2023-12-062023-12-0815,000— $015,000SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise deriv2023-09-152023-09-191,333— $02,667SEC↗
TARS Tarsus Pharmaceuticals, In M Exercise2023-09-152023-09-191,333— $01,333SEC↗
ZLAB Zai Lab Ltd A Award2023-06-292023-06-3018,903$26.45 $500.0K26,248SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2023-06-222023-06-265,000— $05,000SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2023-06-222023-06-263,350— $03,350SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2023-06-152023-06-2015,000— $015,000SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2023-06-072023-06-0916,200— $016,200SEC↗
VERA Vera Therapeutics, Inc. A Award deriv2023-05-102023-05-1220,000— $020,000SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2022-10-062022-10-1114,000— $014,000SEC↗
TARS Tarsus Pharmaceuticals, In A Award deriv2022-10-062022-10-114,000— $04,000SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0630,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-063,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,600— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-0615,000— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-067,500— $00SEC↗
GBT Global Blood Therapeutics, D To issuer deriv2022-10-052022-10-065,247— $00SEC↗
GBT Global Blood Therapeutics, D To issuer2022-10-052022-10-066,637— $00SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2022-08-112022-08-1515,000— $015,000SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2022-06-152022-06-1715,000— $015,000SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2022-06-142022-06-163,600— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-06-142022-06-165,600— $05,600SEC↗
GBT Global Blood Therapeutics, A Award deriv2022-06-142022-06-163,600— $03,600SEC↗
GBT Global Blood Therapeutics, M Exercise2022-06-142022-06-163,600— $06,637SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2022-06-092022-06-1011,000— $011,000SEC↗
VERA Vera Therapeutics, Inc. A Award deriv2022-05-242022-05-269,925— $09,925SEC↗
ZLAB Zai Lab Ltd A Award2021-10-182021-10-187,345— $07,345SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2021-09-092021-09-1315,000— $015,000SEC↗
GBT Global Blood Therapeutics, S Sale2021-09-092021-09-104,800$30.21 $145.0K3,037SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-06-172021-06-213,600— $03,600SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2021-06-172021-06-213,037— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2021-06-172021-06-215,600— $05,600SEC↗
GBT Global Blood Therapeutics, M Exercise2021-06-172021-06-213,037— $07,837SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2021-06-152021-06-1615,000— $015,000SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2021-06-102021-06-1611,000— $011,000SEC↗
VERA Vera Therapeutics, Inc. A Award deriv2021-05-132021-05-179,925— $09,925SEC↗
GBT Global Blood Therapeutics, M Exercise deriv2020-06-172020-06-194,800— $00SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-06-172020-06-195,247— $05,247SEC↗
GBT Global Blood Therapeutics, A Award deriv2020-06-172020-06-193,037— $03,037SEC↗
GBT Global Blood Therapeutics, M Exercise2020-06-172020-06-194,800— $04,800SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2020-06-162020-06-1811,000— $011,000SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2020-06-092020-06-1215,000— $015,000SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2020-03-192020-03-2315,000— $015,000SEC↗
BOLD Audentes Therapeutics, Inc D To issuer deriv2020-01-152020-01-1533,635— $00SEC↗
BOLD Audentes Therapeutics, Inc D To issuer deriv2020-01-152020-01-1516,200— $00SEC↗
BOLD Audentes Therapeutics, Inc D To issuer deriv2020-01-152020-01-1510,000— $00SEC↗
BOLD Audentes Therapeutics, Inc D To issuer deriv2020-01-152020-01-159,000— $00SEC↗
BOLD Audentes Therapeutics, Inc D To issuer deriv2020-01-152020-01-159,000— $00SEC↗
IDYA IDEAYA Biosciences, Inc. A Award deriv2019-09-242019-12-191,250— $01,250SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2019-06-202019-06-2415,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-06-182019-06-207,500— $07,500SEC↗
GBT Global Blood Therapeutics, A Award deriv2019-06-182019-06-204,800— $04,800SEC↗
BOLD Audentes Therapeutics, Inc A Award deriv2019-02-062019-02-0816,200— $016,200SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2018-06-212018-06-2515,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2018-06-202018-06-2215,000— $015,000SEC↗
BOLD Audentes Therapeutics, Inc A Award deriv2018-06-082018-06-0810,000— $010,000SEC↗
BOLD Audentes Therapeutics, Inc A Award deriv2017-10-082017-10-109,000— $09,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2017-06-202017-06-2215,000— $015,000SEC↗
CRVS Corvus Pharmaceuticals, In A Award deriv2017-06-082017-06-0915,000— $015,000SEC↗
BOLD Audentes Therapeutics, Inc A Award deriv2016-08-242016-08-259,000— $09,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-06-162016-06-1715,000— $015,000SEC↗
GBT Global Blood Therapeutics, A Award deriv2016-01-042016-01-0430,000— $030,000SEC↗